1V-LSD L-tartrate or 1-valeryl-lysergic acid diethylamide hami-L-tartrate, a psychedelic drug of the lysergamide class based on ergoline, also called Valerie. A relatively new substance and…
View More 1V-LSD
Category: New Research
New designer drugs, new legal drugs, new research chemicals
BOD (4-methyl-2,5,β-trimethoxyphenethylamine)
BOD or 4-methyl-2,5,β-trimethoxyphenethylamine is a new designer psychedelic analog of 2C-D. BOD acts as a hallucinogenic drug, distorts reality and can cause a feeling of…
View More BOD (4-methyl-2,5,β-trimethoxyphenethylamine)
Flubrotizolam
Flubrotizolam or FANAX is a new benzodiazepine drug, belongs to the derivatives of thienotriazolodiazepine and has anxiolytic, amnesic, anticonvulsant and strong sedative properties. Flubrotizolam and…
View More Flubrotizolam
Kleferein (3,4-CFP)
Kleferein (3,4-CFP) or 3-Chloro-4-fluorophenylpiperazine is a new psychoactive designer drug of the phenylpiperazine class. Kleferein affects the body in a similar way to MDMA…
View More Kleferein (3,4-CFP)
Cyputylone
Cyputylone is a designer stimulant with pathogenic properties, synthesized as a replacement for eutylone and patented as a designer drug. Cyputylone is a new substance…
View More Cyputylone
threo-4-Methylmethylphenidate, 4-MeTMP
threo-4-Methylmethylphenidate or 4-MeTMP is a new drug, a stimulant has a chemical structure closely related to methylphenidate. threo-4-Methylmethylphenidate, unlike methylphenidate, has a less pronounced euphoria…
View More threo-4-Methylmethylphenidate, 4-MeTMP
Rilmazafone (Rhythmy)
Rilmazafone (Rhythmy) hydrochloride is a benzodiazepine drug that affects benzodiazepine receptors. Rilmazafone is metabolized by aminopeptidase enzymes inside the body, has sedative, hypnotic properties. For…
View More Rilmazafone (Rhythmy)
Fluorexetamine (FXE)
Fluorexetamine (FXE) or 3′ – Fluoro-2-oxo-PCE is a new design dissociative, belongs to the arylcyclohexylamine class. Fluorexetamine affects the body as a dissociative agent, changes…
View More Fluorexetamine (FXE)
MDA-19
MDA-19 is a drug that is an agonist of the CB2 and CB1 cannabinoid receptors with some differences. MDA-19 was originally synthesized for the treatment…
View More MDA-19
ADBB(ADB-Butinaca)
ADBB(ADB-Butinaca) is a new designer cannabinoid based on indole, an analog of MDMA-Butinaca and has a similar molecular structure. ADB-Butinaca is a potent agonist of…
View More ADBB(ADB-Butinaca)